Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms
出版年份 2017 全文链接
标题
Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-07-25
DOI
10.3389/fphar.2017.00487
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data
- (2017) S. Dombrowski et al. OSTEOPOROSIS INTERNATIONAL
- Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study
- (2017) L. D. Carbone et al. OSTEOPOROSIS INTERNATIONAL
- Dipeptidyl peptidase-4 inhibitors and bone metabolism: is vitamin D the link?
- (2016) I. Barchetta et al. ACTA DIABETOLOGICA
- DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes – A systematic review and meta-analysis
- (2016) Jil Mamza et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk of fractures and diabetes medications: a nationwide cohort study
- (2016) H. J. Choi et al. OSTEOPOROSIS INTERNATIONAL
- Dipeptidyl peptidase-4 inhibitors and fracture risk: an updated meta-analysis of randomized clinical trials
- (2016) Jianying Fu et al. Scientific Reports
- Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice
- (2015) M. Pereira et al. BONE
- Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report
- (2015) Y H M Krul-Poel et al. Cardiovascular Diabetology
- Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
- (2015) Sho-ichi Yamagishi et al. Cardiovascular Diabetology
- Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus
- (2015) Masakazu Notsu et al. CLINICAL ENDOCRINOLOGY
- Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus
- (2015) Sity Aishah Mansur et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance
- (2015) Tianpeng Zheng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Potential impact of sitagliptin on collagen-derived dipeptides in diabetic osteoporosis
- (2015) L. Baerts et al. PHARMACOLOGICAL RESEARCH
- DPP4 in diabetes
- (2015) Diana Röhrborn Frontiers in Immunology
- Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice
- (2014) Yuwei Wu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats
- (2014) Lorenzo Glorie et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells
- (2014) María Laura Sbaraglini et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women
- (2014) Sahar Kamal Hegazy JOURNAL OF BONE AND MINERAL METABOLISM
- Blockade of CD26 Signaling Inhibits Human Osteoclast Development
- (2014) Hiroko Nishida et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Antidiabetic therapy effects on bone metabolism and fracture risk
- (2013) A. Montagnani et al. DIABETES OBESITY & METABOLISM
- Bone loss in the oestrogen-depleted rat is not exacerbated by sitagliptin, either alone or in combination with a thiazolidinedione
- (2013) T. Cusick et al. DIABETES OBESITY & METABOLISM
- The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
- (2013) Emily Jane Gallagher et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor
- (2013) Guillaume Mabilleau et al. JOURNAL OF ENDOCRINOLOGY
- Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
- (2013) Ju-Young Kim et al. LIFE SCIENCES
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*
- (2011) Mathijs C. BUNCK et al. Journal of Diabetes
- Differential Effects of PPAR-γ ActivationversusChemical or Genetic Reduction of DPP-4 Activity on Bone Quality in Mice
- (2010) Kimberly A. Kyle et al. ENDOCRINOLOGY
- Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor
- (2010) Bernardo Nuche-Berenguer et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Four-month treatment with GLP-2 significantly increases hip BMD
- (2009) Dennis B. Henriksen et al. BONE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started